Tomas Navratil

CHIEF DEVELOPMENT OFFICER

Tomas Navratil (CHIEF DEVELOPMENT OFFICER) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Glaukos Corporation (GKOS). The largest single filing was $2.5M of GKOS (13,734 sh across 2 lots, as filed), executed Aug 28.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 3 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$2.8M

shares × price, as filed

Last traded

Aug 28

Filed Sep 1

Median ADV $192.4M across their filed names

Open performance→

Volume by month

Buys $0 Sells $3.8M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 3 filings

Sector per market data · by filing · past 12 months

Most traded names

GKOS

Glaukos Corporation GKOS · 0 buys · 5 sells 5 filings

Recent filings

GKOSSALE Glaukos Corporation View filing → $2.5M
13,734 sh across 2 lots
Exec Aug 28
Filed Sep 1 · 6:24 PM ET GKOSSALE Glaukos Corporation View filing → $201K
1,537 sh × $130.68
Exec Jun 16
Filed Jun 18 · 5:30 PM ET GKOSSALE Glaukos Corporation View filing → $144K
1,237 sh × $116.72
Exec Apr 10
Filed Apr 14 · 5:30 PM ET GKOSSALE Glaukos Corporation View filing → $454K
5,142 sh across 2 lots
Exec Sep 11 2025
Filed Sep 12 2025 · 5:30 PM ET GKOSSALE Glaukos Corporation View filing → $503K
3,416 sh × $147.14
Exec Feb 14 2025
Filed Feb 19 2025 · 5:30 PM ET